Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Kasper Bruun"'
Autor:
Carlen Reyes, Luz M León-Muñoz, Andrea Pistillo, Sigrún Alba Jóhannesdóttir Schmidt, Kasper Bruun Kristensen, Diana Puente, Ana LLorente-García, Consuelo Huerta-Álvarez, Anton Pottegård, Talita Duarte-Salles
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: A previous study in Denmark suggested an increased melanoma risk associated with the use of flecainide.Objective: To study the association between flecainide use and the risk of melanoma and non-melanoma skin cancer in Spain and Denmark.M
Externí odkaz:
https://doaj.org/article/8bef4fd1264342a993e82f6a72d83414
Autor:
Alesia A. Zuccala, Janne Pölönen, Raf Guns, Vidar Røeggen, Emanuel Kulczycki, Kasper Bruun, Eeva Savolainen
Publikováno v:
Quantitative Science Studies, Vol 2, Iss 2, Pp 588-615 (2021)
AbstractThis study compares publisher ratings to the visibility and impact of individual books, based on a 2017 data set from three Nordic performance-based research funding systems (PRFS) (Denmark, Norway, and Finland). Although there are Journal Im
Externí odkaz:
https://doaj.org/article/6bc24ce910ee4d4e8f24614d7e23dcf3
Autor:
Filippos Giannopoulos, Martin Gillstedt, Marta Laskowski, Kasper Bruun Kristensen, Sam Polesie
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 1, p adv00365 (2021)
An association between methotrexate use and risk of cutaneous squamous cell carcinoma has been reported in patients with rheumatoid and psoriatic arthritis. A nested case-control study was performed to investigate if methotrexate use among patients w
Externí odkaz:
https://doaj.org/article/2722e17da8cc4367983353408117ed52
Autor:
Lars Christian Lund, Kasper Bruun Kristensen, Mette Reilev, Steffen Christensen, Reimar Wernich Thomsen, Christian Fynbo Christiansen, Henrik Støvring, Nanna Borup Johansen, Nikolai Constantin Brun, Jesper Hallas, Anton Pottegård
Publikováno v:
PLoS Medicine, Vol 17, Iss 9, p e1003308 (2020)
BackgroundConcerns over the safety of non-steroidal anti-inflammatory drug (NSAID) use during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been raised. We studied whether use of NSAIDs was associated with adverse outcom
Externí odkaz:
https://doaj.org/article/acc9fd793d9e4eefaa91ba9ebec563a5
Autor:
Hicks, Blánaid, Kaye, James A., Azoulay, Laurent, Kristensen, Kasper Bruun, Habel, Laurel A., Pottegård, Anton
Publikováno v:
In Annals of Epidemiology August 2023 84:25-32
Autor:
Bønnelykke-Behrndtz, Marie Louise, Kristensen, Kasper Bruun, Hölmich, Lisbet Rosenkrantz, Pottegård, Anton
Publikováno v:
In Cancer Epidemiology June 2023 84
Autor:
Marie Louise Bønnelykke-Behrndtz, Kasper Bruun Kristensen, Lisbet Rosenkrantz Hölmich, Anton Pottegård
Publikováno v:
Bønnelykke-Behrndtz, M L, Kristensen, K B, Hölmich, L R & Pottegård, A 2023, ' Tranexamic acid use is not associated with the risk of melanoma in Danish women : A nested case-control study using Danish health registries ', Cancer Epidemiology, vol. 84, 102356 . https://doi.org/10.1016/j.canep.2023.102356
Background: Repurposing already approved drugs in a cancer setting has gained increasing interest in recent years. Tranexamic acid is an anti-fibrinolytic drug that has recently been suggested as an anti-cancer drug due to its anti-inflammatory and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfd4093d01b2828056a357dbcdeb644c
https://pure.au.dk/portal/da/publications/tranexamic-acid-use-is-not-associated-with-the-risk-of-melanoma-in-danish-women(bf7574c8-eb9d-4d0c-9e27-0639a9dadd50).html
https://pure.au.dk/portal/da/publications/tranexamic-acid-use-is-not-associated-with-the-risk-of-melanoma-in-danish-women(bf7574c8-eb9d-4d0c-9e27-0639a9dadd50).html
Autor:
Blánaid Hicks, James A. Kaye, Laurent Azoulay, Kasper Bruun Kristensen, Laurel A. Habel, Anton Pottegård
Publikováno v:
Hicks, B, Kaye, J A, Azoulay, L, Bruun Kristensen, K, Habel, L A & Pottegård, A 2023, ' The application of lag times in cancer pharmacoepidemiology: a narrative review ', Annals of Epidemiology, vol. 84, pp. 25-32 . https://doi.org/10.1016/j.annepidem.2023.05.004
PurposeWith the increasing utilization of medications worldwide, coupled with the increasing availability of long-term data, there is a growing opportunity and need for robust studies evaluating drug–cancer associations. One methodology of importan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80710c6b54f7f0cba5616b809b17b38f
https://doi.org/10.1016/j.annepidem.2023.05.004
https://doi.org/10.1016/j.annepidem.2023.05.004
Autor:
Anton Pottegård, Laurel A. Habel, Bettina K. Andreassen, Chris R. Cardwell, Jesper Hallas, Lars Christian Lund, Søren Friis, Kasper Bruun Kristensen
The main tool in drug safety monitoring, spontaneous reporting of adverse effects, is unlikely to detect delayed adverse drug effects including cancer. Hypothesis-free screening studies based on administrative data could improve ongoing drug safety m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af49733f3bb396349740f5980693f81
https://doi.org/10.1158/2767-9764.c.6551025
https://doi.org/10.1158/2767-9764.c.6551025
Autor:
Anton Pottegård, Laurel A. Habel, Bettina K. Andreassen, Chris R. Cardwell, Jesper Hallas, Lars Christian Lund, Søren Friis, Kasper Bruun Kristensen
Online Supplementary Material for publication containing additional information on covariate definitions (table S1 - S2) and statistical methods (methods S3) as well as the number of cases and examined drugs for each cancer under examination (table S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f1bca5216c89bff1b7929abaafe9961
https://doi.org/10.1158/2767-9764.22545756.v1
https://doi.org/10.1158/2767-9764.22545756.v1